Wednesday, 23 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14475
Articles
Company
Drug
Hainan Poly Pharm’s Generic Ganciclovir Approved in Sweden for CMV Retinitis
February 2, 2025
Company
Drug
Bio-Thera’s BAT1806 Biosimilar Accepted for Review by European Medicine Agency
February 2, 2025
Company
Deals
Kactus Biosystems Raises RMB 200M in Series B Financing for Protein and Enzyme Development
February 2, 2025
Company
Deals
Shandong Junxiu Biotechnology Secures RMB 45M in Series B Financing
February 2, 2025
Company
Drug
Brii Biosciences Reports Positive Phase I Results for HIV Treatments BRII-732 and BRII-778
February 2, 2025
Company
Bayer to Set Up Shenzhen Unit to Boost Women’s Healthcare in South China
February 2, 2025
Company
Drug
GenScript’s Legend Biotech Reports USD 55M in Carvykti Sales
February 2, 2025
Company
Drug
YiChang HEC ChangJiang Pharma’s Insulin Aspart Gains NMPA Approval
February 2, 2025
Company
Drug
Henlius Biotech’s Hanbeitai Gains NMPA Approval for Recurrent Glioblastoma
February 2, 2025
Company
Policy / Regulatory
NHSA Responds to Proposal on Dental Implants’ Inclusion in NRDL
February 2, 2025
Company
Johnson & Johnson Reports Q3 Sales Growth, Maintains Full-Year Guidance
February 2, 2025
Company
Deals
Sichuan Biokin Pharma Plans IPO on STAR Board to Raise RMB 1.422 Billion
February 2, 2025
1
2
…
1,118
1,119
1,120
1,121
1,122
…
1,206
1,207
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?